Back to top
more

Immunomedics, Inc. (IMMU)

(Delayed Data from NSDQ)

$14.74 USD

14.74
2,889,678

-0.16 (-1.07%)

Updated May 3, 2019 04:00 PM ET

After-Market: $14.75 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Immunomedics (IMMU) Jumps: Stock Rises 5.4%

Immunomedics (IMMU) was a big mover last session, as the company saw its shares more than 5% on the day amid huge volumes.

    Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?

    Investors in Immunomedics (IMMU) need to pay close attention to the stock based on moves in the options market lately.

      Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?

      Investors in Immunomedics (IMMU) need to pay close attention to the stock based on moves in the options market lately.

        Immunomedics (IMMU) Catches Eye: Stock Up 5.1%

        Immunomedics (IMMU) was a big mover last session, as the company saw its shares rise over 5% on the day amid huge volumes.

          Zacks.com featured highlights: Glu Mobile, Calumet Specialty Products Partners, The Bancorp, Immunomedics and Hudbay Minerals

          Zacks.com featured highlights: Glu Mobile, Calumet Specialty Products Partners, The Bancorp, Immunomedics and Hudbay Minerals

            Immunomedics' Progress in Phase II Cancer Study Encouraging

            Immunomedics, Inc. (IMMU) announced encouraging interim results from a phase II study on its cancer candidate, labetuzumab govitecan. Shares were up 7% on Monday in response.

              Kevin Matras headshot

              Explosive Stocks Under $10

              Kevin Matras looks for stocks under $10 with explosive potential. Highlighted stocks include GLUU, CLMT, TBBK, IMMU and HBM.

                Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?

                Immunomedics (IMMU) warrants investors' attention based on moves in the options market lately.

                  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock

                  Investors in Immunomedics (IMMU) need to pay close attention to the stock based on moves in the options market lately.

                    Joseph Lu headshot

                    Immunomedics (IMMU) Stock Soars After Deal with Seattle Genetics Is Halted

                    Immunomedics, Inc. (IMMU) stock soared in midday trading Thursday following the stop on the company's deal with Seattle Genetics (SGEN) after the lawsuit filed by Immunomedics' largest investor, venBio Select Advisor LLC, reported by The Street.

                      Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?

                      Immunomedics (IMMU) warrants investors' attention based on moves in the options market lately.

                        Immunomedics (IMMU) Worth a Look: Stock Climbs 7%

                        Immunomedics, Inc. (IMMU) shares rose almost 7% in the last trading session.

                          Immunomedics Completes Enrollment In Cancer Drug Study

                          Immunomedics (IMMU) achieved the planned enrollment in a phase II study on IMMU-132.